Legend Biotech
Legend Biotech Corporation, a prominent player in the biotechnology industry, is headquartered in Somerset, New Jersey, with significant operations in various regions, including Asia and Europe. Founded in 2014, the company has rapidly advanced in the field of cell therapy, particularly focusing on innovative treatments for cancer and other serious diseases. Legend Biotech is renowned for its flagship product, CAR-T cell therapy, which harnesses the power of the immune system to target and eliminate cancer cells. This unique approach sets it apart in a competitive market, positioning the company as a leader in the development of cutting-edge therapies. With a commitment to research and development, Legend Biotech has achieved notable milestones, including successful clinical trials and partnerships that enhance its market presence and drive future growth.
DitchCarbon Score
How does Legend Biotech's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Development industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Legend Biotech's score of 20 is lower than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Legend Biotech's reported carbon emissions
In 2023, Legend Biotech reported total carbon emissions of approximately 12.97 million tonnes CO2e. This figure includes about 770,000 tonnes CO2e from Scope 1 emissions, primarily from stationary combustion, and approximately 12.20 million tonnes CO2e from Scope 2 emissions, which are associated with purchased electricity. Currently, there are no publicly stated reduction targets or initiatives from Legend Biotech, indicating a potential area for future commitment in climate action. The absence of specific reduction goals suggests that the company may be in the early stages of developing a comprehensive climate strategy. As the biopharmaceutical industry increasingly prioritises sustainability, Legend Biotech's future commitments will be crucial in aligning with global climate objectives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project2023 | |
|---|---|
| Scope 1 | 770,000 |
| Scope 2 | 12,204,000 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Legend Biotech is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
